The session is to give a comprehensive overview of the utilization of iron-oxide based MRI contrast agents in oncological liver imaging, both to visualize the vascular architecture of the liver with T1-weighted images as well as to detect focal liver lesions by means of T2-weighted sequences.
Introduction
Peter Reimer, Karlsruhe / Germany
General overview of nanoparticle-based MRI
Peter Reimer, Karlsruhe / Germany
New approach to MRI upper abdominal imaging – selected case studies
Christian Krestan, Wien / Austria
Utility of nanoparticle-based MRI liver imaging for interventional radiology
Tobias Jakobs, München / Germany